title: [Chronic myeloid leukemia].
authors.affiliation: Division of Molecular Therapy, Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo.
authors.forename: Arinobu
authors.initials: A
authors.lastname: Tojo
mesh_terms: D000069439:Dasatinib; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy*; D058990:Molecular Targeted Therapy / Q000379:methods*; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors*; D011724:Pyridazines / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use; D013844:Thiazoles / Q000627:therapeutic use
chemical_list: D007093:Imidazoles; D047428:Protein Kinase Inhibitors; D011724:Pyridazines; D011743:Pyrimidines; D013844:Thiazoles; C545373:ponatinib; D011505:Protein-Tyrosine Kinases; C498826:nilotinib; D000069439:Dasatinib